Showing: 1 - 10 of 28 RESULTS
Briefing Mind Cure Health Psychedelics

Mindcure Ends Fiscal Q1 2022 With $15.6 Million Cash & Cash Equivalents, $2.8 Million Net Loss

Mind Cure Health (CSE: MCUR) announced on Tuesday the financial results for the three months ended August 31, 2021. The firm ended the quarter with a $2.8 million net loss compared to fiscal Q1 2021’s net loss of $0.3 million. Among the company’s expenses for the quarter include $1.0 million in consulting fees and payroll, $0.2 …

Briefing Mind Cure Health News Psychedelics

Mind Cure Health Receives Ethics Approval For Psychedelic Integration Protocol Study

Mind Cure Health (CSE: MCUR) has seen its integration protocol research study receive unconditional ethics approval. The study is being conducted in connection with the development of iSTRYM, the firms digital therapeutics platform. The ethics approval, which comes from Veritas IRB, effectively ensures that processes included in research studies respects participants rights and that they …

Briefing Mind Cure Health News Psychedelics

Mind Cure Health Appoints Rob Hill To Board Of Directors

Mind Cure Health (CSE: MCUR) this morning announced the appointment of Rob Hill to the firms board of directors. The appointment is said to strengthen the firms use of tech in the development of psychedelic-related treatments, given Hill’s extensive expertise in heavily regulated markets. Hill reportedly has extensive experience in managing both private and public …

Briefing Mind Cure Health News Psychedelics

Mind Cure Health Focuses On Research Into Psychedelics For Traumatic Brain Injury

Mind Cure Health (CSE: MCUR) as of this morning has seen the transition of one of its advisory board members to that of primary investigator consultant. Dr Dan Engle will be transitioning to the new role, as the company begins focusing on its research into the treatment of traumatic brain injury with psychedelics. Originally appointed …

Briefing Mind Cure Health News Psychedelics

Mind Cure Set To Launch Products Into Psychedelic Therapy Adaptogen Supplement Category

Mind Cure Health (CSE: MCUR) has completed the development of its first products. The company has completed the proprietary formulations for what it refers to as “all-natural integrated medicines intended to prepare and support patients of psychedelic therapies.” The first two products, referred to as Mindful Preparation and Mindful Integration, are intended as pre and …